Arnon Rosenthal
Vermögen: 14 Mio $ am 31.05.2026
Vermögen: 14 Mio $ am 31.05.2026
Arnon Rosenthal was the founder of Annexon, Inc. (founded in 2011, titled: Chairman from 2014 to 2017), Rinat Neuroscience Corp.
(founded in 2001, titled: President, Director & Chief Scientific Officer from 2001 to 2006), and Alector, Inc. (founded in 2013, titled: Chief Executive Officer & Director since 2019).
Former job at Genentech, Inc. as Scientist from 1985 to 2001.
Education includes a doctorate from The Hebrew University of Jerusalem.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALECTOR, INC. 5.67% | 02.06.2026 | 6’297’581 ( 5.67% ) | 14 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ALECTOR, INC. | Gründer | 01.05.2013 |
| Unternehmen | Position | Ende |
|---|---|---|
| ANNEXON, INC. | Vorstandsvorsitzender | 01.12.2014 |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Gründer | 01.08.2006 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01.08.2001 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Annexon, Inc.
Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Health Technology |
Alector, Inc.
Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen